Compugen Ltd (CGEN) - Debt to Equity

The visual price representation available on GURU.Markets illustrates the total debt-to-equity ratio for Compugen Ltd. (CGEN), which stands at 0.03. A team with a deep scientific background, focused on the commercialization of oncology innovations, defines the company's strategic course. The business relies on AI platforms for accelerated target protein selection, while Israeli developments are protected by humanitarian status and integrated into US clinics.

Searching for fundamentally resilient assets requires strict control over financial leverage. This metric is calculated as the ratio of total liabilities to equity, measuring the extent of a business's dependence on borrowed funds. For Compugen Ltd. (CGEN), which is scaling autonomous AI platforms in computational biology, this balance is critical when financing costly research and development. Analyzing the total debt-to-equity ratio allows for an assessment of undercapitalization risk. The trend in the total debt-to-equity ratio determines the sustainability of the company's strategy.